Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Exercise × Other × Clear all

Phase

Phase NA 18 Phase 4 3 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Breast 2 Other 1 Head & Neck 1 Genitourinary 1

Conditions

Obesity 1 Motor Activity 1 Breast Neoplasms 1

Interventions

tegaserod 1 semaglutide 1 penclomedine 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Thioctic Acid 1 Tablets 1 Radiation 1 Metformin 1 Megestrol Acetate 1 Low-Level Light Therapy 1 Lidocaine 1 Exercise 1 Exenatide 1 Diphenhydramine 1 Buspirone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00393172 2019-11-01

WISER

University of Minnesota

Phase 2/3 Completed

Breast Neoplasms, Motor Activity, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡